Global Pharmacogenomics Services Market Growth (Status and Outlook) 2024-2031

Report ID: 1545848 | Published Date: Oct 2024 | No. of Page: 113 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Pharmacogenomics Services Market Size 2017-2028
        2.1.2 Pharmacogenomics Services Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Pharmacogenomics Services Segment by Type
        2.2.1 Genotyping
        2.2.2 SNP Identification
        2.2.3 Pharmacogenetic Testing
        2.2.4 Others
    2.3 Pharmacogenomics Services Market Size by Type
        2.3.1 Pharmacogenomics Services Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Pharmacogenomics Services Market Size Market Share by Type (2017-2022)
    2.4 Pharmacogenomics Services Segment by Application
        2.4.1 Oncology
        2.4.2 Infectious Diseases
        2.4.3 Psychiatry
        2.4.4 Cardiovascular
        2.4.5 Others
    2.5 Pharmacogenomics Services Market Size by Application
        2.5.1 Pharmacogenomics Services Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Pharmacogenomics Services Market Size Market Share by Application (2017-2022)
3 Pharmacogenomics Services Market Size by Player
    3.1 Pharmacogenomics Services Market Size Market Share by Players
        3.1.1 Global Pharmacogenomics Services Revenue by Players (2020-2022)
        3.1.2 Global Pharmacogenomics Services Revenue Market Share by Players (2020-2022)
    3.2 Global Pharmacogenomics Services Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Pharmacogenomics Services by Regions
    4.1 Pharmacogenomics Services Market Size by Regions (2017-2022)
    4.2 Americas Pharmacogenomics Services Market Size Growth (2017-2022)
    4.3 APAC Pharmacogenomics Services Market Size Growth (2017-2022)
    4.4 Europe Pharmacogenomics Services Market Size Growth (2017-2022)
    4.5 Middle East & Africa Pharmacogenomics Services Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Pharmacogenomics Services Market Size by Country (2017-2022)
    5.2 Americas Pharmacogenomics Services Market Size by Type (2017-2022)
    5.3 Americas Pharmacogenomics Services Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Pharmacogenomics Services Market Size by Region (2017-2022)
    6.2 APAC Pharmacogenomics Services Market Size by Type (2017-2022)
    6.3 APAC Pharmacogenomics Services Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Pharmacogenomics Services by Country (2017-2022)
    7.2 Europe Pharmacogenomics Services Market Size by Type (2017-2022)
    7.3 Europe Pharmacogenomics Services Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Pharmacogenomics Services by Region (2017-2022)
    8.2 Middle East & Africa Pharmacogenomics Services Market Size by Type (2017-2022)
    8.3 Middle East & Africa Pharmacogenomics Services Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Pharmacogenomics Services Market Forecast
    10.1 Global Pharmacogenomics Services Forecast by Regions (2023-2028)
        10.1.1 Global Pharmacogenomics Services Forecast by Regions (2023-2028)
        10.1.2 Americas Pharmacogenomics Services Forecast
        10.1.3 APAC Pharmacogenomics Services Forecast
        10.1.4 Europe Pharmacogenomics Services Forecast
        10.1.5 Middle East & Africa Pharmacogenomics Services Forecast
    10.2 Americas Pharmacogenomics Services Forecast by Country (2023-2028)
        10.2.1 United States Pharmacogenomics Services Market Forecast
        10.2.2 Canada Pharmacogenomics Services Market Forecast
        10.2.3 Mexico Pharmacogenomics Services Market Forecast
        10.2.4 Brazil Pharmacogenomics Services Market Forecast
    10.3 APAC Pharmacogenomics Services Forecast by Region (2023-2028)
        10.3.1 China Pharmacogenomics Services Market Forecast
        10.3.2 Japan Pharmacogenomics Services Market Forecast
        10.3.3 Korea Pharmacogenomics Services Market Forecast
        10.3.4 Southeast Asia Pharmacogenomics Services Market Forecast
        10.3.5 India Pharmacogenomics Services Market Forecast
        10.3.6 Australia Pharmacogenomics Services Market Forecast
    10.4 Europe Pharmacogenomics Services Forecast by Country (2023-2028)
        10.4.1 Germany Pharmacogenomics Services Market Forecast
        10.4.2 France Pharmacogenomics Services Market Forecast
        10.4.3 UK Pharmacogenomics Services Market Forecast
        10.4.4 Italy Pharmacogenomics Services Market Forecast
        10.4.5 Russia Pharmacogenomics Services Market Forecast
    10.5 Middle East & Africa Pharmacogenomics Services Forecast by Region (2023-2028)
        10.5.1 Egypt Pharmacogenomics Services Market Forecast
        10.5.2 South Africa Pharmacogenomics Services Market Forecast
        10.5.3 Israel Pharmacogenomics Services Market Forecast
        10.5.4 Turkey Pharmacogenomics Services Market Forecast
        10.5.5 GCC Countries Pharmacogenomics Services Market Forecast
    10.6 Global Pharmacogenomics Services Forecast by Type (2023-2028)
    10.7 Global Pharmacogenomics Services Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Information
        11.1.2 Abbott Laboratories Pharmacogenomics Services Product Offered
        11.1.3 Abbott Laboratories Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Abbott Laboratories Main Business Overview
        11.1.5 Abbott Laboratories Latest Developments
    11.2 Admera Health, LLC
        11.2.1 Admera Health, LLC Company Information
        11.2.2 Admera Health, LLC Pharmacogenomics Services Product Offered
        11.2.3 Admera Health, LLC Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Admera Health, LLC Main Business Overview
        11.2.5 Admera Health, LLC Latest Developments
    11.3 Mesa Laboratories, Inc.
        11.3.1 Mesa Laboratories, Inc. Company Information
        11.3.2 Mesa Laboratories, Inc. Pharmacogenomics Services Product Offered
        11.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Mesa Laboratories, Inc. Main Business Overview
        11.3.5 Mesa Laboratories, Inc. Latest Developments
    11.4 Dynamic DNA Laboratories
        11.4.1 Dynamic DNA Laboratories Company Information
        11.4.2 Dynamic DNA Laboratories Pharmacogenomics Services Product Offered
        11.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Dynamic DNA Laboratories Main Business Overview
        11.4.5 Dynamic DNA Laboratories Latest Developments
    11.5 F. Hoffmann-La Roche Ltd.
        11.5.1 F. Hoffmann-La Roche Ltd. Company Information
        11.5.2 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Offered
        11.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
        11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
    11.6 GeneOmbio Technologies Pvt Ltd.
        11.6.1 GeneOmbio Technologies Pvt Ltd. Company Information
        11.6.2 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Offered
        11.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 GeneOmbio Technologies Pvt Ltd. Main Business Overview
        11.6.5 GeneOmbio Technologies Pvt Ltd. Latest Developments
    11.7 Exact Sciences Corporation
        11.7.1 Exact Sciences Corporation Company Information
        11.7.2 Exact Sciences Corporation Pharmacogenomics Services Product Offered
        11.7.3 Exact Sciences Corporation Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Exact Sciences Corporation Main Business Overview
        11.7.5 Exact Sciences Corporation Latest Developments
    11.8 Illumina, Inc.
        11.8.1 Illumina, Inc. Company Information
        11.8.2 Illumina, Inc. Pharmacogenomics Services Product Offered
        11.8.3 Illumina, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Illumina, Inc. Main Business Overview
        11.8.5 Illumina, Inc. Latest Developments
    11.9 Laboratory Corporation of America Holdings
        11.9.1 Laboratory Corporation of America Holdings Company Information
        11.9.2 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Offered
        11.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Laboratory Corporation of America Holdings Main Business Overview
        11.9.5 Laboratory Corporation of America Holdings Latest Developments
    11.10 Myriad Genetics, Inc.
        11.10.1 Myriad Genetics, Inc. Company Information
        11.10.2 Myriad Genetics, Inc. Pharmacogenomics Services Product Offered
        11.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Myriad Genetics, Inc. Main Business Overview
        11.10.5 Myriad Genetics, Inc. Latest Developments
    11.11 OmeCare
        11.11.1 OmeCare Company Information
        11.11.2 OmeCare Pharmacogenomics Services Product Offered
        11.11.3 OmeCare Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 OmeCare Main Business Overview
        11.11.5 OmeCare Latest Developments
    11.12 QIAGEN N.V.
        11.12.1 QIAGEN N.V. Company Information
        11.12.2 QIAGEN N.V. Pharmacogenomics Services Product Offered
        11.12.3 QIAGEN N.V. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 QIAGEN N.V. Main Business Overview
        11.12.5 QIAGEN N.V. Latest Developments
    11.13 Quest Diagnostics Incorporated
        11.13.1 Quest Diagnostics Incorporated Company Information
        11.13.2 Quest Diagnostics Incorporated Pharmacogenomics Services Product Offered
        11.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Quest Diagnostics Incorporated Main Business Overview
        11.13.5 Quest Diagnostics Incorporated Latest Developments
    11.14 Thermo Fisher Scientific Inc.
        11.14.1 Thermo Fisher Scientific Inc. Company Information
        11.14.2 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Offered
        11.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Thermo Fisher Scientific Inc. Main Business Overview
        11.14.5 Thermo Fisher Scientific Inc. Latest Developments
    11.15 Precipio
        11.15.1 Precipio Company Information
        11.15.2 Precipio Pharmacogenomics Services Product Offered
        11.15.3 Precipio Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Precipio Main Business Overview
        11.15.5 Precipio Latest Developments
    11.16 23andMe, Inc.
        11.16.1 23andMe, Inc. Company Information
        11.16.2 23andMe, Inc. Pharmacogenomics Services Product Offered
        11.16.3 23andMe, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 23andMe, Inc. Main Business Overview
        11.16.5 23andMe, Inc. Latest Developments
    11.17 OneOme, LLC
        11.17.1 OneOme, LLC Company Information
        11.17.2 OneOme, LLC Pharmacogenomics Services Product Offered
        11.17.3 OneOme, LLC Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 OneOme, LLC Main Business Overview
        11.17.5 OneOme, LLC Latest Developments
    11.18 DiaCarta, Inc.
        11.18.1 DiaCarta, Inc. Company Information
        11.18.2 DiaCarta, Inc. Pharmacogenomics Services Product Offered
        11.18.3 DiaCarta, Inc. Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 DiaCarta, Inc. Main Business Overview
        11.18.5 DiaCarta, Inc. Latest Developments
    11.19 OPKO Health
        11.19.1 OPKO Health Company Information
        11.19.2 OPKO Health Pharmacogenomics Services Product Offered
        11.19.3 OPKO Health Pharmacogenomics Services Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 OPKO Health Main Business Overview
        11.19.5 OPKO Health Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Pharmacogenomics Services Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Genotyping
    Table 3. Major Players of SNP Identification
    Table 4. Major Players of Pharmacogenetic Testing
    Table 5. Major Players of Others
    Table 6. Pharmacogenomics Services Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 7. Global Pharmacogenomics Services Market Size by Type (2017-2022) & ($ Millions)
    Table 8. Global Pharmacogenomics Services Market Size Market Share by Type (2017-2022)
    Table 9. Pharmacogenomics Services Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 10. Global Pharmacogenomics Services Market Size by Application (2017-2022) & ($ Millions)
    Table 11. Global Pharmacogenomics Services Market Size Market Share by Application (2017-2022)
    Table 12. Global Pharmacogenomics Services Revenue by Players (2020-2022) & ($ Millions)
    Table 13. Global Pharmacogenomics Services Revenue Market Share by Player (2020-2022)
    Table 14. Pharmacogenomics Services Key Players Head office and Products Offered
    Table 15. Pharmacogenomics Services Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 16. New Products and Potential Entrants
    Table 17. Mergers & Acquisitions, Expansion
    Table 18. Global Pharmacogenomics Services Market Size by Regions 2017-2022 & ($ Millions)
    Table 19. Global Pharmacogenomics Services Market Size Market Share by Regions (2017-2022)
    Table 20. Americas Pharmacogenomics Services Market Size by Country (2017-2022) & ($ Millions)
    Table 21. Americas Pharmacogenomics Services Market Size Market Share by Country (2017-2022)
    Table 22. Americas Pharmacogenomics Services Market Size by Type (2017-2022) & ($ Millions)
    Table 23. Americas Pharmacogenomics Services Market Size Market Share by Type (2017-2022)
    Table 24. Americas Pharmacogenomics Services Market Size by Application (2017-2022) & ($ Millions)
    Table 25. Americas Pharmacogenomics Services Market Size Market Share by Application (2017-2022)
    Table 26. APAC Pharmacogenomics Services Market Size by Region (2017-2022) & ($ Millions)
    Table 27. APAC Pharmacogenomics Services Market Size Market Share by Region (2017-2022)
    Table 28. APAC Pharmacogenomics Services Market Size by Type (2017-2022) & ($ Millions)
    Table 29. APAC Pharmacogenomics Services Market Size Market Share by Type (2017-2022)
    Table 30. APAC Pharmacogenomics Services Market Size by Application (2017-2022) & ($ Millions)
    Table 31. APAC Pharmacogenomics Services Market Size Market Share by Application (2017-2022)
    Table 32. Europe Pharmacogenomics Services Market Size by Country (2017-2022) & ($ Millions)
    Table 33. Europe Pharmacogenomics Services Market Size Market Share by Country (2017-2022)
    Table 34. Europe Pharmacogenomics Services Market Size by Type (2017-2022) & ($ Millions)
    Table 35. Europe Pharmacogenomics Services Market Size Market Share by Type (2017-2022)
    Table 36. Europe Pharmacogenomics Services Market Size by Application (2017-2022) & ($ Millions)
    Table 37. Europe Pharmacogenomics Services Market Size Market Share by Application (2017-2022)
    Table 38. Middle East & Africa Pharmacogenomics Services Market Size by Region (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Region (2017-2022)
    Table 40. Middle East & Africa Pharmacogenomics Services Market Size by Type (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Type (2017-2022)
    Table 42. Middle East & Africa Pharmacogenomics Services Market Size by Application (2017-2022) & ($ Millions)
    Table 43. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Application (2017-2022)
    Table 44. Key Market Drivers & Growth Opportunities of Pharmacogenomics Services
    Table 45. Key Market Challenges & Risks of Pharmacogenomics Services
    Table 46. Key Industry Trends of Pharmacogenomics Services
    Table 47. Global Pharmacogenomics Services Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 48. Global Pharmacogenomics Services Market Size Market Share Forecast by Regions (2023-2028)
    Table 49. Global Pharmacogenomics Services Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 50. Global Pharmacogenomics Services Market Size Market Share Forecast by Type (2023-2028)
    Table 51. Global Pharmacogenomics Services Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 52. Global Pharmacogenomics Services Market Size Market Share Forecast by Application (2023-2028)
    Table 53. Abbott Laboratories Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 54. Abbott Laboratories Pharmacogenomics Services Product Offered
    Table 55. Abbott Laboratories Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 56. Abbott Laboratories Main Business
    Table 57. Abbott Laboratories Latest Developments
    Table 58. Admera Health, LLC Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 59. Admera Health, LLC Pharmacogenomics Services Product Offered
    Table 60. Admera Health, LLC Main Business
    Table 61. Admera Health, LLC Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 62. Admera Health, LLC Latest Developments
    Table 63. Mesa Laboratories, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 64. Mesa Laboratories, Inc. Pharmacogenomics Services Product Offered
    Table 65. Mesa Laboratories, Inc. Main Business
    Table 66. Mesa Laboratories, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 67. Mesa Laboratories, Inc. Latest Developments
    Table 68. Dynamic DNA Laboratories Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 69. Dynamic DNA Laboratories Pharmacogenomics Services Product Offered
    Table 70. Dynamic DNA Laboratories Main Business
    Table 71. Dynamic DNA Laboratories Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 72. Dynamic DNA Laboratories Latest Developments
    Table 73. F. Hoffmann-La Roche Ltd. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 74. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Offered
    Table 75. F. Hoffmann-La Roche Ltd. Main Business
    Table 76. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 77. F. Hoffmann-La Roche Ltd. Latest Developments
    Table 78. GeneOmbio Technologies Pvt Ltd. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 79. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Offered
    Table 80. GeneOmbio Technologies Pvt Ltd. Main Business
    Table 81. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 82. GeneOmbio Technologies Pvt Ltd. Latest Developments
    Table 83. Exact Sciences Corporation Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 84. Exact Sciences Corporation Pharmacogenomics Services Product Offered
    Table 85. Exact Sciences Corporation Main Business
    Table 86. Exact Sciences Corporation Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 87. Exact Sciences Corporation Latest Developments
    Table 88. Illumina, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 89. Illumina, Inc. Pharmacogenomics Services Product Offered
    Table 90. Illumina, Inc. Main Business
    Table 91. Illumina, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 92. Illumina, Inc. Latest Developments
    Table 93. Laboratory Corporation of America Holdings Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 94. Laboratory Corporation of America Holdings Pharmacogenomics Services Product Offered
    Table 95. Laboratory Corporation of America Holdings Main Business
    Table 96. Laboratory Corporation of America Holdings Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 97. Laboratory Corporation of America Holdings Latest Developments
    Table 98. Myriad Genetics, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 99. Myriad Genetics, Inc. Pharmacogenomics Services Product Offered
    Table 100. Myriad Genetics, Inc. Main Business
    Table 101. Myriad Genetics, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 102. Myriad Genetics, Inc. Latest Developments
    Table 103. OmeCare Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 104. OmeCare Pharmacogenomics Services Product Offered
    Table 105. OmeCare Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 106. OmeCare Main Business
    Table 107. OmeCare Latest Developments
    Table 108. QIAGEN N.V. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 109. QIAGEN N.V. Pharmacogenomics Services Product Offered
    Table 110. QIAGEN N.V. Main Business
    Table 111. QIAGEN N.V. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 112. QIAGEN N.V. Latest Developments
    Table 113. Quest Diagnostics Incorporated Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 114. Quest Diagnostics Incorporated Pharmacogenomics Services Product Offered
    Table 115. Quest Diagnostics Incorporated Main Business
    Table 116. Quest Diagnostics Incorporated Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 117. Quest Diagnostics Incorporated Latest Developments
    Table 118. Thermo Fisher Scientific Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 119. Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Offered
    Table 120. Thermo Fisher Scientific Inc. Main Business
    Table 121. Thermo Fisher Scientific Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 122. Thermo Fisher Scientific Inc. Latest Developments
    Table 123. Precipio Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 124. Precipio Pharmacogenomics Services Product Offered
    Table 125. Precipio Main Business
    Table 126. Precipio Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 127. Precipio Latest Developments
    Table 128. 23andMe, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 129. 23andMe, Inc. Pharmacogenomics Services Product Offered
    Table 130. 23andMe, Inc. Main Business
    Table 131. 23andMe, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 132. 23andMe, Inc. Latest Developments
    Table 133. OneOme, LLC Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 134. OneOme, LLC Pharmacogenomics Services Product Offered
    Table 135. OneOme, LLC Main Business
    Table 136. OneOme, LLC Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 137. OneOme, LLC Latest Developments
    Table 138. DiaCarta, Inc. Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 139. DiaCarta, Inc. Pharmacogenomics Services Product Offered
    Table 140. DiaCarta, Inc. Main Business
    Table 141. DiaCarta, Inc. Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 142. DiaCarta, Inc. Latest Developments
    Table 143. OPKO Health Details, Company Type, Pharmacogenomics Services Area Served and Its Competitors
    Table 144. OPKO Health Pharmacogenomics Services Product Offered
    Table 145. OPKO Health Main Business
    Table 146. OPKO Health Pharmacogenomics Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 147. OPKO Health Latest Developments
List of Figures
    Figure 1. Pharmacogenomics Services Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Pharmacogenomics Services Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Pharmacogenomics Services Market Size Market Share by Type in 2021
    Figure 7. Pharmacogenomics Services in Oncology
    Figure 8. Global Pharmacogenomics Services Market: Oncology (2017-2022) & ($ Millions)
    Figure 9. Pharmacogenomics Services in Infectious Diseases
    Figure 10. Global Pharmacogenomics Services Market: Infectious Diseases (2017-2022) & ($ Millions)
    Figure 11. Pharmacogenomics Services in Psychiatry
    Figure 12. Global Pharmacogenomics Services Market: Psychiatry (2017-2022) & ($ Millions)
    Figure 13. Pharmacogenomics Services in Cardiovascular
    Figure 14. Global Pharmacogenomics Services Market: Cardiovascular (2017-2022) & ($ Millions)
    Figure 15. Pharmacogenomics Services in Others
    Figure 16. Global Pharmacogenomics Services Market: Others (2017-2022) & ($ Millions)
    Figure 17. Global Pharmacogenomics Services Market Size Market Share by Application in 2021
    Figure 18. Global Pharmacogenomics Services Revenue Market Share by Player in 2021
    Figure 19. Global Pharmacogenomics Services Market Size Market Share by Regions (2017-2022)
    Figure 20. Americas Pharmacogenomics Services Market Size 2017-2022 ($ Millions)
    Figure 21. APAC Pharmacogenomics Services Market Size 2017-2022 ($ Millions)
    Figure 22. Europe Pharmacogenomics Services Market Size 2017-2022 ($ Millions)
    Figure 23. Middle East & Africa Pharmacogenomics Services Market Size 2017-2022 ($ Millions)
    Figure 24. Americas Pharmacogenomics Services Value Market Share by Country in 2021
    Figure 25. Americas Pharmacogenomics Services Consumption Market Share by Type in 2021
    Figure 26. Americas Pharmacogenomics Services Market Size Market Share by Application in 2021
    Figure 27. United States Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Canada Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Mexico Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Brazil Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 31. APAC Pharmacogenomics Services Market Size Market Share by Region in 2021
    Figure 32. APAC Pharmacogenomics Services Market Size Market Share by Application in 2021
    Figure 33. China Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Japan Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Korea Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Southeast Asia Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 37. India Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 38. Australia Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Europe Pharmacogenomics Services Market Size Market Share by Country in 2021
    Figure 40. Europe Pharmacogenomics Services Market Size Market Share by Type in 2021
    Figure 41. Europe Pharmacogenomics Services Market Size Market Share by Application in 2021
    Figure 42. Germany Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 43. France Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 44. UK Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 45. Italy Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Russia Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Region in 2021
    Figure 48. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Type in 2021
    Figure 49. Middle East & Africa Pharmacogenomics Services Market Size Market Share by Application in 2021
    Figure 50. Egypt Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 51. South Africa Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 52. Israel Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 53. Turkey Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 54. GCC Country Pharmacogenomics Services Market Size Growth 2017-2022 ($ Millions)
    Figure 55. Americas Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 56. APAC Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 57. Europe Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 58. Middle East & Africa Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 59. United States Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 60. Canada Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 61. Mexico Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 62. Brazil Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 63. China Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 64. Japan Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 65. Korea Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 66. Southeast Asia Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 67. India Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 68. Australia Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 69. Germany Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 70. France Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 71. UK Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 72. Italy Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 73. Russia Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 74. Spain Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 75. Egypt Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 76. South Africa Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 77. Israel Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 78. Turkey Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
    Figure 79. GCC Countries Pharmacogenomics Services Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Pharmacogenomics Services Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Pharmacogenomics Services Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Pharmacogenomics Services Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports